A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants
Clinical trial NCT05806359 · COMPLETED
Trial details
- NCT number
- NCT05806359
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-31
- Primary completion
- 2023-08-14
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.